Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Glucans as New Anticancer Agents

P. Sima, J. Richter, V. Vetvicka,

. 2019 ; 39 (7) : 3373-3378. [pub] -

Jazyk angličtina Země Řecko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc19034466

For decades, glucans have been studied for their biological and immunological activities. The scientific community has mainly focused on immune reactions, but other areas, such as cholesterol levels and diabetic retinopathy, have shown the positive effects of glucan supplementation. However, the majority of studies focused on possible cancer suppression, where glucans showed clear and significant effects on numerous types of cancers, leading not only to clinical trials, but to approval as an official drug. The aim of this review is to describe the current knowledge of this field.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19034466
003      
CZ-PrNML
005      
20191010110637.0
007      
ta
008      
191007s2019 gr f 000 0|eng||
009      
AR
024    7_
$a 10.21873/anticanres.13480 $2 doi
035    __
$a (PubMed)31262858
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gr
100    1_
$a Sima, Petr $u Department of Immunology, Institute of Microbiology, Prague, Czech Republic.
245    10
$a Glucans as New Anticancer Agents / $c P. Sima, J. Richter, V. Vetvicka,
520    9_
$a For decades, glucans have been studied for their biological and immunological activities. The scientific community has mainly focused on immune reactions, but other areas, such as cholesterol levels and diabetic retinopathy, have shown the positive effects of glucan supplementation. However, the majority of studies focused on possible cancer suppression, where glucans showed clear and significant effects on numerous types of cancers, leading not only to clinical trials, but to approval as an official drug. The aim of this review is to describe the current knowledge of this field.
650    _2
$a zvířata $7 D000818
650    _2
$a protinádorové látky $x farmakologie $x terapeutické užití $7 D000970
650    _2
$a glukany $x farmakologie $x terapeutické užití $7 D005936
650    _2
$a lidé $7 D006801
650    _2
$a nádory $x farmakoterapie $7 D009369
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Richter, Josef $u Institute of Public Health in Usti nad Labem, Ústí nad Labem, Czech Republic.
700    1_
$a Vetvicka, Vaclav $u Department of Pathology and Laboratory Medicine, University of Louisville, Louisville, KY, U.S.A. vaclav.vetvicka@louisville.edu.
773    0_
$w MED00000478 $t Anticancer research $x 1791-7530 $g Roč. 39, č. 7 (2019), s. 3373-3378
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31262858 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20191010111056 $b ABA008
999    __
$a ok $b bmc $g 1451126 $s 1073016
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 39 $c 7 $d 3373-3378 $e - $i 1791-7530 $m Anticancer research $n Anticancer Res $x MED00000478
LZP    __
$a Pubmed-20191007

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...